Invesco Biotechnology & Genome ETF (PBE)

Invesco Biotechnology & Genome ETF (PBE) is an exchange-traded fund in the Health category. It has $277.92M in assets, an expense ratio of 0.58% and a 1.73% dividend yield. The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.